Håkon Reikvam
- Hematology top 0.5%
- Acute Myeloid Leukemia Research 72
- Hematopoietic Stem Cell Transplantation 27
- Chronic Myeloid Leukemia Treatments 15
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 12
- Hemoglobinopathies and Related Disorders 12
- Internal Medicine top 5%
- Immunology top 5%
- Cancer Research top 5%
-
- Histone Deacetylase Inhibitors Research 21
- Retinoids in leukemia and cellular processes 15
-
- Blood transfusion and management 11
- Co-authors
- Øystein BruserudKimberley Joanne HatfieldIna NepstadIda Sofie GrønningsæterAnnette K. BrennerKnut Anders MosevollTor Henrik Anderson TvedtBjørn Tore Gjertsen
- Cited by
- HematologyGeneticsInternal Medicine
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (10 papers)Blood (2 papers)
- Partner nations
- NorwayUnited StatesSpain
In The Last Decade
Håkon Reikvam
158 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Hematology 1.5k
- Genetics 406
- Internal Medicine 96
- Immunology 523
- Cancer Research 339
Countries citing papers authored by Håkon Reikvam
This map shows the geographic impact of Håkon Reikvam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Håkon Reikvam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Håkon Reikvam more than expected).
Fields of papers citing papers by Håkon Reikvam
This network shows the impact of papers produced by Håkon Reikvam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Håkon Reikvam. The network helps show where Håkon Reikvam may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Håkon Reikvam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 16 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 18 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 7 | |
| 13 | 2022 | 0 | |
| 14 | 2021 | 5 | |
| 15 | 2021 | 78 | |
| 16 | 2021 | 17 | |
| 17 | 2020 | 2 | |
| 18 | 2013 | 10 | |
| 19 | 2012 | 46 | |
| 20 | 2011 | 17 |
About Håkon Reikvam
Håkon Reikvam is a scholar working on Hematology, Genetics and Biochemistry, having authored 180 papers that have together received 3.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (72 papers), Hematopoietic Stem Cell Transplantation (27 papers), Histone Deacetylase Inhibitors Research (21 papers), Retinoids in leukemia and cellular processes (15 papers), Chronic Myeloid Leukemia Treatments (15 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Hemoglobinopathies and Related Disorders (12 papers) and Blood transfusion and management (11 papers). The work is most often cited by research in Hematology (1.5k citations), Genetics (406 citations) and Internal Medicine (96 citations). Håkon Reikvam has collaborated with scholars based in Norway, United States and Spain. Frequent co-authors include Øystein Bruserud, Kimberley Joanne Hatfield, Ina Nepstad, Ida Sofie Grønningsæter, Annette K. Brenner, Knut Anders Mosevoll, Tor Henrik Anderson Tvedt, Bjørn Tore Gjertsen, Tor Hervig and Astrid Olsnes Kittang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.